Research fuels our mission to end cancer
Many of the greatest minds in cancer research are at MD Anderson. They're here because MD Anderson offers a unique environment that accelerates their ability to end cancer. They collaborate with other cancer experts – in different research areas and with the world's leading cancer doctors. Bright students and trainees contribute further to our dynamic research environment. Discoveries are fueled by vast research support and resources. Tomorrow's medicine is available to our patients first since we have the most cancer clinical trials in the world. These research efforts work in parallel to fight cancer through prevention, early diagnosis, effective therapies and scientific breakthroughs.
2019 CPRIT Funding
for core facility support
In August, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded more than $19 million to MD Anderson in support of research, recruitment and prevention efforts. MD Anderson and its projects have received $466.6 million, or 19.5%, of CPRIT’s total funding since the agency began making awards in 2009.
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer. MD Anderson's reach is comprehensive when it comes to eliminating cancer.
Our laboratories cover the full breadth of cancer research. They’re led by some of the leading scientists and physicians in the world.
Scientists from different disciplines come together to focus on a common area in our research institutes.
Moon Shots Program
Inspired by an unprecedented era of scientific discovery a generation ago, the Moon Shots Program™ was launched by MD Anderson as an ambitious plan to make a giant leap in cancer research to benefit patients.Learn more about the Moon Shots Program
Phase IB study
Lung cancer progression
CAR T-Cell Therapy
MD Anderson receives $55 million over five years in comprehensive cancer center status renewal
MD Anderson has been renewed as a National Cancer Institute (NCI)-designated comprehensive cancer center. The federal funding program will grant MD Anderson a total of $55 million over five years, supporting 16 research programs, 14 shared resource services and four developing cores. This renewal marks MD Anderson’s 48th consecutive year with the designation.
Leukemia Texas Research Grant
Project looks to develop chemotherapy-preventive approach to leukemias with hereditary mutations